Literature DB >> 24135217

Vitamin D deficiency: consequence or cause of CKD?

Ian H de Boer1, Ravi Thadhani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24135217      PMCID： PMC3817913          DOI： 10.2215/CJN.09480913

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  26 in total

1.  Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

Authors:  A S Brickman; J W Coburn; A W Norman
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

2.  Biological activity of 1,25-dihydroxycholecalciferol.

Authors:  J Omdahl; M Holick; T Suda; Y Tanaka; H F DeLuca
Journal:  Biochemistry       Date:  1971-07-20       Impact factor: 3.162

3.  Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism.

Authors:  D E Lawson; D R Fraser; E Kodicek; H R Morris; D H Williams
Journal:  Nature       Date:  1971-03-26       Impact factor: 49.962

4.  Biological activity of a polar metabolite of vitamin D.

Authors:  E Kodicek; D E Lawson; P W Wilson
Journal:  Nature       Date:  1970-11-21       Impact factor: 49.962

5.  Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.

Authors:  D L Andress; K C Norris; J W Coburn; E A Slatopolsky; D J Sherrard
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

6.  22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats.

Authors:  Michinori Hirata; Kojiro Makibayashi; Kyoko Katsumata; Kenichiro Kusano; Takeshi Watanabe; Naoshi Fukushima; Toshio Doi
Journal:  Nephrol Dial Transplant       Date:  2002-12       Impact factor: 5.992

7.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors:  Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Authors:  E Slatopolsky; C Weerts; J Thielan; R Horst; H Harter; K J Martin
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.

Authors:  Alexander Kuhlmann; Christian S Haas; Marie-Luise Gross; Udo Reulbach; Marc Holzinger; Ute Schwarz; Eberhard Ritz; Kerstin Amann
Journal:  Am J Physiol Renal Physiol       Date:  2003-11-04

10.  25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.

Authors:  Gema Fernández-Juárez; José Luño; Vicente Barrio; Soledad García de Vinuesa; Manuel Praga; Marian Goicoechea; Vicente Lahera; Luisa Casas; Jesús Oliva
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 8.237
View more
  2 in total

1.  Vitamin D deficiency--prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis--a prospective multicenter study.

Authors:  Adalbert Schiller; Florica Gadalean; Oana Schiller; Romulus Timar; Flaviu Bob; Mircea Munteanu; Dana Stoian; Adelina Mihaescu; Bogdan Timar
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

Review 2.  The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach.

Authors:  Charlotte Delrue; Reinhart Speeckaert; Joris R Delanghe; Marijn M Speeckaert
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.